CP-I
Caplin Point Laboratories Ltd Unit-I (CP-I) is a WHO-GMP approved facility, situated in Suthukeny, which is about 20 km from Puducherry.
The company has the facilities to manufacture :
- Sterile Penem Injectables
- Tablets
- Capsules
- Liquid Orals (Syrup & Suspension)
- Soft Gelatin Capsules
- Dry powder for Oral Suspension
- Suppositories and Ovules
Location : Suthukeny, Puducherry
CP-II
Caplin Point has set up a dedicated pharmaceutical R&D facility with capabilities to develop safe and effective formulations. Sophisticated facilities and resources are available to develop dosage forms like Tablets, Capsules, Semi-solids (including suppositories), Liquid orals, Granules and Soft Geltin Capsules. The R & D facility is having separate teams for formulation development and analytical development. R & D scale stability studies, forced degradation studies, method development and validations are carried out in-house.
The following range of services are provided :
- Design and development of new dosage forms as per customer needs
- Process improvements and optimization
- Stability studies as per ICH guidelines
- Analytical development and Method validations as per ICH
- Technology transfer of new developed formulations
- Dissolution profiles as per CDER/EU guidelines
Location : Gummidipoondi, Chennai
CP-III / Argus
Caplin Point Laboratories Ltd Unit-III (Argus) is situated in the foothills town of Baddi in Himachal Pradesh with a panoramic view on Pinjore Nalagarh highway.
CP-III has the modern machinery to manufacture the topical formulations such as Ointments, Creams, Gels, Lotions and Capsules.
Location : Baddi, Himachal Pradesh
CP-IV
Caplin Point Laboratories Limited, Unit – IV (CP-IV) is an EU-GMP and ANVISA approved manufacturing facility handling Pharmaceutical formulations in Specialized Injectable dosage forms and Ophthalmic drops. The facility is designed with a high level of sophistication and automated process control and is in compliance with norms stated by US FDA, UK MHRA and other regulatory bodies belonging to PIC/s.
The Site has a dedicated facility for formulation development, analytical development and stability department for product development in sterile dosage forms.
CP-IV is capable of handling general category and specialized category injectable dosages in Vial, Ampoules, Lyophilized Vials and Ophthalmic dosages.
The plant capacity is :
- Ampoules : 25 Million units per annum
- Vial : 25 Million units per annum
- Lyophilized Vials : 1.2 Million units per annum
- Ophthalmics : 12 Million units per annum
Location : Gummidipoondi, Chennai